Table 2.
Morpho-functional cardiac abnormalities
| Before n (%)/mean (SD) | After n (%)/mean (SD) | P | |
|---|---|---|---|
| Increased LV end diastolic volume | 23 (58%) | 9 (22%) | 0.003 |
| Increased septal thickness | 24 (60%) | 10 (25%) | 0.003 |
| Normal LV geometry | 16 (40%) | 31 (78%) | 0.001 |
| LV hypertrophy or concentric remodeling | 24 (60%) | 9 (22%) | 0.001 |
| LV hypertrophy | 10 (25%) | 2 (5%) | 0.028 |
| Concentric hypertrophy | 7 (17%) | 2 (5%) | 0.157 |
| Eccentric hypertrophy | 3 (8%) | 0 | 0.124 |
| LV concentric remodeling | 14 (35%) | 7 (18%) | 0.127 |
| Increased LA area | 30 (75%) | 14 (35%) | 0.001 |
| Diastolic dysfunction | 4 (10%) | 0 | 0.124 |
| GLS >-18% | 17 (43%) | 0 | <0.001 |
| Epicardial fat thickness, mm | 4.7±1 | 3.5±0.7 | <0.001 |
LV, left ventricular; LA, left atrial; GLS, global longitudinal strain.